Bacterial superantigen staphylococcal enterotoxin B induces interstitial pneumonia in SCID mice reconstituted with peripheral blood mononuclear cells from collagen vascular disease patients

Clinical Immunology

Volumn 96, Issue 1, 2000, Pages 38-43

  Fujiki, Misae ^a   Shinbori, Toshifumi ^a   Suga, Moritaka ^a   Miyakawa, Hisako ^a   Mizobe, Takanori ^a   Ando, Masayuki ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Collagen vascular disease; Interstitial pneumonia; SCID mice; Superantigen

Indexed keywords

CD45 ANTIGEN; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; COLLAGEN DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; INTERSTITIAL PNEUMONIA; LEUKOCYTE; MALE; MEMORY CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE; VASCULAR DISEASE;

EID: 0033949903     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4872     Document Type: Article

References (28)

1. Arsura E. L., Greenberg A. S. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin. Arthritis Rheum. 18:1988;29-37.
2. Gross M., Esterly J. R., Earle R. H. Pulmonary alterations in systemic lupus erythematosus. Am. Rev. Respir. Dis. 105:1972;572-577.
3. Rossi G. A., Bitterman P. B., Rennard S. I., Ferrans V. J., Crystal R. G. Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am. Rev. Respir. Dis. 131:1985;612-617.
4. Roschmann R. A., Rothenberg R. J. Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy. Semin. Arthritis Rheum. 16:1987;174-185.
5. Hunninghake G. W., Fauci A. S. Pulmonary involvement in collagen vascular diseases. Am. Rev. Respir. Dis. 119:1979;471-503.
6. Lynch J. P., Hunninghake G. W. Pulmonary complications of collagen vascular disease. Annu. Rev. Med. 43:1992;17-35.
7. Nagai S., Izumi T. Immunopathology of collagen vascular disease. Curr. Opin. Pulm. Med. 3:1992;356-360.
8. Shinbori T., Matsuki M., Suga M., Kakimoto K., Ando M. Induction of interstitial pneumonia in autoimmune mice by intratracheal administration of superantigen staphylococcal enterotoxin B. Cell. Immunol. 174:1996;129-137.
9. White J., Herman A., Pullen A. M., Kubo R., Kappler J. W., Marrack P. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 56:1989;27-35.
10. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 24:1990;705-711.
11. Paliard X., West S. G., Lafferty J. A., Clements J. R., Kappler J. W., Marrack P., Kotzin B. L. Evidence for the effects of a superantigen in rheumatoid arthritis. Science. 25:1991;325-329.
12. Conrad B., Weidmann E., Trucco G., Rudert W. A., Behboo R., Ricordi C., Rodriquez-Rili H., Finegold D., Trucco M. Evidence for superantigen involvement in insulin-dependent diabetes aetiology. Nature. 371:1994;351-355.
13. Bosma M. J. The scid mutation: Occurrence and effect. Curr. Top. Microbiol. 152:1989;3-9.
14. Dorshkind K. Use of the scid mouse transplantation system in studies of lymphocyte differentiation. Curr. Top. Microbiol. 152:1989;169-172.
15. Bosma M. J., Carroll A. M. The scid mouse mutant: Definition, characterization, and potential uses. Annu. Rev. Immunol. 9:1991;323-350.
16. Mosier D. E., Gulizia R. J., Baird S. M., Wilson D. B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 335:1988;256-259.
17. McCune J. M. Scid mice as immune system models. Curr. Opin. Immunol. 3:1991;224-228.
18. Duchosal M. A., McConahey P. J., Robinson C. A., Dixon F. J. Transfer of human systemic lupuserythematosus in severe combined immunodeficient (SCID) mice. J. Exp. Med. 172:1990;985-988.
19. Kräling B. M., Juhasz I., Freundlich B., Maul G. G., Jimenez S. A. Transplantation of systemic sclerosis (SSc) skin graft into severe combined immunodeficient mice. Pathobiology. 64:1996;99-114.
20. Fox R. I., Pisa P., Pisa E. K., Kang H. Lymphoproliferative disease in SCID mice reconstituted with human Sjögren's syndrome lymphocytes. J. Clin. Lab. Anal. 7:1993;46-56.
21. Duchosal M. A., Eming S. A., McConahey P. J., Dixon F. J. Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease. Am. J. Pathol. 141:1992;1097-1113.
22. Elkon K. B., Ashany D. The SCID mouse as vehicle to study autoimmunity. Br. J. Rheumatol. 32:1993;4-12.
23. Murphy W. J., Bennett M., Anver M. R., Baseler M., Longo D. L. Human-mouse lymphoid chimeras: Host-vs.-graft and graft-vs.-host reactions. Eur. J. Immunol. 22:1992;1421-1427.
24. Huppes W., Fickenscher H., Thart B. A., Fleckenstein B. Cytokine dependence of human to mouse graft-versus-host disease. Scand. J. Immunol. 40:1994;26-36.
25. Jodo S., Kobayashi S., Kayagaki N., Ogura N., Feng Y., Amasaki Y., Fujisaku A., Azuma M., Yagita H., Okumura K., Koike T. Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases. Clin. Exp. Immunol. 107:1997;89-95.
26. Suda T., Hashimoto H., Tanaka M., Ochi T., Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J. Exp. Med. 186:1997;2045-2050.
27. Hashimoto H., Tanaka M., Suda T., Tomita T., Hayashida K., Takeuchi E., Kaneko M., Takano H., Nagata S., Ochi T. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 41:1998;657-662.
28. Takahashi, T., Munakata, M., Ohtsuka, Y., Satoh, A., Homma, Y., and Kawakami, Y., Role of viral infection in acute exacerbation of idiopathic interstitial pneumonia. Jpn. J. Thoracic Dis.33, 723-727, (in Japanese).